Applied Materials Inc. income statement & cash flow
In the fiscal year ended Oct 26, 2025, Applied Materials Inc. reported net income of $7.00B on revenue of $28.37B. Operating cash flow was $7.96B and capital expenditures were $2.26B, leaving $5.70B of free cash flow (operating cash flow minus capital expenditures).
Income statement and cash flow summary
| Fiscal year ended | Oct 2016 | Oct 2017 | Oct 2018 | Oct 2019 | Oct 2020 | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.82B | $14.70B | $16.70B | $14.61B | $17.20B | $23.06B | $25.79B | $26.52B | $27.18B | $28.37B |
| Gross profit | $4.51B | $6.61B | $7.52B | $6.39B | $7.69B | $10.91B | $11.99B | $12.38B | $12.90B | $13.81B |
| Operating income | $2.15B | $3.94B | $4.49B | $3.35B | $4.37B | $6.89B | $7.79B | $7.65B | $7.87B | $8.29B |
| Net income | $1.72B | $3.52B | $3.04B | $2.71B | $3.62B | $5.89B | $6.53B | $6.86B | $7.18B | $7.00B |
| Diluted EPS | $1.54 | $3.25 | $2.96 | $2.86 | $3.92 | $6.40 | $7.44 | $8.11 | $8.61 | $8.66 |
| Operating cash flow | $2.57B | $3.79B | $3.79B | $3.25B | $3.80B | $5.44B | $5.40B | $8.70B | $8.68B | $7.96B |
| Capital expenditures | $253.00M | $345.00M | $622.00M | $441.00M | $422.00M | $668.00M | $787.00M | $1.11B | $1.19B | $2.26B |
| Reported in | 10-K 2018 | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2025 | 10-K 2025 |
Margins
Each figure divided by revenue for the same fiscal year.
| Fiscal year ended | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| Oct 2025 | 48.7% | 29.2% | 24.7% |
| Oct 2024 | 47.5% | 28.9% | 26.4% |
| Oct 2023 | 46.7% | 28.9% | 25.9% |
| Oct 2022 | 46.5% | 30.2% | 25.3% |
| Oct 2021 | 47.3% | 29.9% | 25.5% |
Source: SEC EDGAR XBRL company facts for CIK 6951 (raw data). Most recent filing in this dataset: 10-Q filed Aug 20, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.